← 產業報告目錄

Radiation Therapy Quality Assurance Phantoms Market Size, Share & Trends Analysis Report By Technology (Linear Accelerators, Cobalt-60, High-Dose Radiation, Low-Dose Radiation), By Therapy, By Region, And By Segment Forecasts, 2025-2034

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-26頁數 185報告編號 INSIGHTACE-caa5196ef1

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

In 2024, the Radiation Therapy Quality Assurance Phantoms Market worldwide was assessed at USD 30.5 Mn. Analysts project it will surge to USD 57.8 Mn by 2034, at a CAGR of 6.7% spanning 2025 to 2034. The Radiation Therapy Quality Assurance Phantoms sector involves key industry insights & findings from the report: Rising demand for phantoms for tumor and cancer treatment is driving the radiation therapy quality assurance phantoms market. This domain has witnessed substantial transformation owing to technological breakthroughs and shifting healthcare dynamics. Market momentum is fueled by surging appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies. The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion. From a regional perspective, mature markets in North America and Europe continue to hold substantial shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and surging investment in the sector. The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion. This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Radiation Therapy Quality Assurance (QA) Phantoms Market Snapshot Chapter 4. Global Radiation Therapy Quality Assurance (QA) Phantoms Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis 5.1. by Technology & Market Share, 2024 & 2034 5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology: 5.2.1. Linear Accelerators 5.2.2. Cobalt-60 5.2.3. High-Dose Radiation 5.2.4. Low-Dose Radiation Chapter 6. Market Segmentation 2: by Therapy Estimates & Trend Analysis 6.1. by Therapy & Market Share, 2024 & 2034 6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Therapy: 6.2.1. External Radiation Therapy 6.2.1.1. Photon Beam Radiation Therapy 6.2.1.2. Advanced three-Dimensional Conformal Radiation Therapy (3-D CRT) 6.2.1.3. Volumetric Modulated Arc Therapy (VMAT) 6.2.1.4. Image Guided Radiation Therapy (IGRT) 6.2.1.5. Stereotactic Radiation Therapy 6.2.1.6. Intraoperative Radiotherapy (IORT) 6.2.1.7. Proton Beam Therapy 6.2.1.8. Neutron Beam Therapy 6.2.2. Internal Radiation Therapy or Brachytherapy Chapter 7. Radiation Therapy Quality Assurance (QA) Phantoms Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Radiation Therapy Quality Assurance (QA) Phantoms Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034 7.1.2. North America Radiation Therapy Quality Assurance (QA) Phantoms Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2021-2034 7.1.3. North America Radiation Therapy Quality Assurance (QA) Phantoms Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 7.2. Europe 7.2.1. Europe Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Technology, 2021-2034 7.2.2. Europe Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Therapy, 2021-2034 7.2.3. Europe Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by country, 2021-2034 7.3. Asia Pacific 7.3.1. Asia Pacific Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Technology, 2021-2034 7.3.2. Asia Pacific Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Therapy, 2021-2034 7.3.3. Asia Pacific Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by country, 2021-2034 7.4. Latin America 7.4.1. Latin America Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Technology, 2021-2034 7.4.2. Latin America Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Therapy, 2021-2034 7.4.3. Latin America Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by country, 2021-2034 7.5. Middle East & Africa 7.5.1. Middle East & Africa Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Technology, 2021-2034 7.5.2. Middle East & Africa Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Therapy, 2021-2034 7.5.3. Middle East & Africa Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by country, 2021-2034 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Computerized Imaging Reference Systems, Inc. 8.2.2. Fluke Biomedical 8.2.3. IBA Dosimetry 8.2.4. Modus Medical Devices Inc. 8.2.5. PTW Freiburg GmbH 8.2.6. Standard Imaging Inc. 8.2.7. Sun Nuclear Corporation 8.2.8. The Phantom Laboratory, Inc. 8.2.9. Other Prominent Players

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們